Trials / Sponsors / SignalRX Pharmaceuticals, Inc.
SignalRX Pharmaceuticals, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma | Phase 1 | 2017-03-27 |